BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 19500261)

  • 1. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ; Wu HC; Hsueh PR
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal.
    Ferreira AS; Sampaio A; Maduro AP; Silva I; Teles F; Martins Mda L; Inácio J
    Mycoses; 2014 Feb; 57(2):98-104. PubMed ID: 23848429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
    Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
    Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
    Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
    Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia.
    Escandón P; Sánchez A; Martínez M; Meyer W; Castañeda E
    FEMS Yeast Res; 2006 Jun; 6(4):625-35. PubMed ID: 16696659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Cryptococcus neoformans isolated from urban environmental sources in Goiânia, Goiás State, Brazil.
    Kobayashi CC; Souza LK; Fernandes Ode F; Brito SC; Silva AC; Sousa ED; Silva Mdo R
    Rev Inst Med Trop Sao Paulo; 2005; 47(4):203-7. PubMed ID: 16138201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans/C. Gattii species complexes of Maceió, Alagoas, Brazil.
    de Holanda Fonseca DL; Silva DMWD; de Albuquerque Maranhão FC
    Braz J Microbiol; 2024 Jun; 55(2):1369-1380. PubMed ID: 38619732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
    Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
    Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
    Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
    Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India.
    Khan ZU; Randhawa HS; Kowshik T; Chowdhary A; Chandy R
    J Antimicrob Chemother; 2007 Aug; 60(2):312-6. PubMed ID: 17553813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.
    Trilles L; Meyer W; Wanke B; Guarro J; Lazéra M
    Med Mycol; 2012 Apr; 50(3):328-32. PubMed ID: 21859388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.
    Silva DC; Martins MA; Szeszs MW; Bonfietti LX; Matos D; Melhem MS
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):332-9. PubMed ID: 22341512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.